• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于免疫检查点基因表达谱的肝细胞癌免疫亚型鉴定和预后评估。

Identification of immune subtypes and prognosis of hepatocellular carcinoma based on immune checkpoint gene expression profile.

机构信息

Department of hepatobiliary and pancreatic surgery, Hainan General Hospital , Hainan Affiliated Hospital of Hainan Medical University, Haikou, Hainan, 570311, China.

Geriatrics center, Hainan General Hospital , Hainan Affiliated Hospital of Hainan Medical University, Haikou, Hainan, 570311, China.

出版信息

Biomed Pharmacother. 2020 Jun;126:109903. doi: 10.1016/j.biopha.2020.109903. Epub 2020 Feb 26.

DOI:10.1016/j.biopha.2020.109903
PMID:32113055
Abstract

The significant response of immunotherapy is currently limited to a small number of patients, which has a high degree of selectivity. Therefore, distinguishing the immune subtypes of the tumor is necessary for patients who may benefit from immune checkpoint therapy. Clinical data and RNA expression data from The Cancer Genome Atlas (TCGA) and GENE EXPRESSION OMNIBUS (GEO) databases were used to study the relationship of immune regulatory pathways with immune subtypes, and the effects on the prognosis of hepatocellular carcinoma (HCC) patients. Eight immune checkpoint coding genes (ICGs) were obtained that closely related to prognosis. Adaptive immune pathway genes (CD8A, CD68, GZMB, and NOS2) show significant positive correlation with most of ICGs. Therefore, adaptive immune pathway genes may play a certain regulatory role in the expression of ICGs. Among the four immune subtypes, the group with low expression level of PD-L1, IDO1 and CTLA4, and high expression of CD8A had showed the best prognosis. The prognosis was the worst in the group with low expression of PD-L1, IDO1 and CTLA4, and showed low expression of CD8A. This research proposed a method to analyze the gene expression profile of immune checkpoints. The present method can be applied to identify the relationship between immune subtype of HCC and the prognosis, providing basis for gene immunotherapy in HCC patients.

摘要

免疫疗法的显著疗效目前仅限于少数具有高度选择性的患者。因此,区分肿瘤的免疫亚型对于可能受益于免疫检查点治疗的患者是必要的。本研究利用来自癌症基因组图谱(TCGA)和基因表达综合数据库(GEO)的临床数据和 RNA 表达数据,研究了免疫调节途径与免疫亚型的关系及其对肝细胞癌(HCC)患者预后的影响。得到了 8 个与预后密切相关的免疫检查点编码基因(ICGs)。适应性免疫途径基因(CD8A、CD68、GZMB 和 NOS2)与大多数 ICGs 呈显著正相关。因此,适应性免疫途径基因可能在 ICGs 的表达中发挥一定的调节作用。在四个免疫亚型中,PD-L1、IDO1 和 CTLA4 表达水平低、CD8A 表达水平高的组显示出最好的预后。PD-L1、IDO1 和 CTLA4 表达水平低、CD8A 表达水平低的组预后最差。本研究提出了一种分析免疫检查点基因表达谱的方法。该方法可用于识别 HCC 的免疫亚型与预后之间的关系,为 HCC 患者的基因免疫治疗提供依据。

相似文献

1
Identification of immune subtypes and prognosis of hepatocellular carcinoma based on immune checkpoint gene expression profile.基于免疫检查点基因表达谱的肝细胞癌免疫亚型鉴定和预后评估。
Biomed Pharmacother. 2020 Jun;126:109903. doi: 10.1016/j.biopha.2020.109903. Epub 2020 Feb 26.
2
Identification of an immune checkpoint gene signature that accurately predicts prognosis and immunotherapy response in endometrial carcinoma.鉴定免疫检查点基因特征,准确预测子宫内膜癌的预后和免疫治疗反应。
Aging (Albany NY). 2021 Jun 22;13(12):16696-16712. doi: 10.18632/aging.203189.
3
Identification of immunologic subtype and prognosis of GBM based on TNFSF14 and immune checkpoint gene expression profiling.基于 TNFSF14 和免疫检查点基因表达谱鉴定 GBM 的免疫亚型和预后。
Aging (Albany NY). 2020 Apr 20;12(8):7112-7128. doi: 10.18632/aging.103065.
4
Immune checkpoint gene signature assesses immune infiltration profiles in bladder cancer and identifies KRT23 as an immunotherapeutic target.免疫检查点基因特征评估膀胱癌中的免疫浸润特征,并确定 KRT23 为免疫治疗靶点。
BMC Cancer. 2024 Aug 19;24(1):1024. doi: 10.1186/s12885-024-12790-w.
5
Identification of an Immunologic Signature of Lung Adenocarcinomas Based on Genome-Wide Immune Expression Profiles.基于全基因组免疫表达谱鉴定肺腺癌的免疫特征
Front Mol Biosci. 2021 Jan 11;7:603701. doi: 10.3389/fmolb.2020.603701. eCollection 2020.
6
Immune Checkpoint Gene Expression Profiling Identifies Programmed Cell Death Ligand-1 Centered Immunologic Subtypes of Oral and Squamous Cell Carcinoma With Favorable Survival.免疫检查点基因表达谱鉴定出以程序性细胞死亡配体-1为中心、具有良好生存预后的口腔鳞状细胞癌免疫亚型。
Front Med (Lausanne). 2022 Jan 20;8:759605. doi: 10.3389/fmed.2021.759605. eCollection 2021.
7
An immune-related biomarker index for predicting the effectiveness of immunotherapy and prognosis in hepatocellular carcinoma.一种用于预测肝细胞癌免疫治疗疗效和预后的免疫相关生物标志物指数。
J Cancer Res Clin Oncol. 2023 Sep;149(12):10319-10333. doi: 10.1007/s00432-023-04899-5. Epub 2023 Jun 5.
8
Identification of bladder cancer subtypes and predictive signature for prognosis, immune features, and immunotherapy based on immune checkpoint genes.基于免疫检查点基因的膀胱癌亚型鉴定及预后、免疫特征和免疫治疗预测标志物。
Sci Rep. 2024 Jun 23;14(1):14431. doi: 10.1038/s41598-024-65198-8.
9
Construction of an immune-related gene signature for prediction of prognosis in patients with cervical cancer.构建用于预测宫颈癌患者预后的免疫相关基因特征。
Int Immunopharmacol. 2020 Nov;88:106882. doi: 10.1016/j.intimp.2020.106882. Epub 2020 Aug 13.
10
Vascular endothelial growth factor receptor-2 and its association with tumor immune regulatory gene expression in hepatocellular carcinoma.血管内皮生长因子受体-2 及其与肝癌免疫调节基因表达的关系。
Aging (Albany NY). 2020 Nov 20;12(24):25172-25188. doi: 10.18632/aging.104119.

引用本文的文献

1
Bulk and single-cell RNA sequencing identify prognostic signatures related to FGFBP2 NK cell in hepatocellular carcinoma.批量和单细胞RNA测序鉴定出与肝细胞癌中FGFBP2自然杀伤细胞相关的预后特征。
PeerJ. 2025 May 20;13:e19337. doi: 10.7717/peerj.19337. eCollection 2025.
2
Integrative genomic analysis and diagnostic modeling of osteoporosis: unraveling the interplay of autophagy, osteogenesis, adipogenesis, and immune infiltration.骨质疏松症的综合基因组分析与诊断模型:揭示自噬、成骨、脂肪生成和免疫浸润之间的相互作用
Front Med (Lausanne). 2025 Apr 17;12:1544390. doi: 10.3389/fmed.2025.1544390. eCollection 2025.
3
Potential predictive value of CD8A and PGF protein expression in gastric cancer patients treated with neoadjuvant immunotherapy.
CD8A和PGF蛋白表达在接受新辅助免疫治疗的胃癌患者中的潜在预测价值。
BMC Cancer. 2025 Apr 12;25(1):674. doi: 10.1186/s12885-025-14046-7.
4
Comprehensive analysis of immune subtype characterization on identification of potential cells and drugs to predict response to immune checkpoint inhibitors for hepatocellular carcinoma.肝细胞癌免疫亚型特征的综合分析:用于识别潜在细胞和药物以预测免疫检查点抑制剂反应
Genes Dis. 2024 Nov 27;12(3):101471. doi: 10.1016/j.gendis.2024.101471. eCollection 2025 May.
5
Prognostic development and validation of a prediction model based on major histocompatibility complex-related differentially expressed genes in stomach adenocarcinoma.基于主要组织相容性复合体相关差异表达基因的胃腺癌预测模型的预后研究与验证
Transl Cancer Res. 2025 Jan 31;14(1):33-61. doi: 10.21037/tcr-24-707. Epub 2025 Jan 21.
6
Expression and clinical significance of NLRC5 in hepatocellular carcinoma.NLRC5 在肝细胞癌中的表达及临床意义。
Cancer Biol Ther. 2024 Dec 31;25(1):2390205. doi: 10.1080/15384047.2024.2390205. Epub 2024 Aug 12.
7
Single‑cell RNA‑seq necroptosis‑related genes predict the prognosis of breast cancer and affect the differentiation of CD4 T cells in tumor immune microenvironment.单细胞RNA测序坏死性凋亡相关基因可预测乳腺癌预后并影响肿瘤免疫微环境中CD4 T细胞的分化。
Mol Clin Oncol. 2024 May 28;21(1):49. doi: 10.3892/mco.2024.2747. eCollection 2024 Jul.
8
Prognostic model incorporating immune checkpoint genes to predict the immunotherapy efficacy for lung adenocarcinoma: a cohort study integrating machine learning algorithms.纳入免疫检查点基因的预后模型预测肺腺癌免疫治疗疗效:一项整合机器学习算法的队列研究。
Immunol Res. 2024 Aug;72(4):851-863. doi: 10.1007/s12026-024-09492-7. Epub 2024 May 16.
9
Bioinformatic analysis of the role of immune checkpoint genes and immune infiltration in the pathogenesis and development of premature ovarian insufficiency.免疫检查点基因在卵巢早衰发病机制和发展中的作用及免疫浸润的生物信息学分析。
J Assist Reprod Genet. 2024 Jun;41(6):1619-1635. doi: 10.1007/s10815-024-03120-x. Epub 2024 May 2.
10
Pyroptosis-Derived Long Noncoding RNA Profiles Reveal a Novel Signature for Evaluating the Prognosis of Patients With Lung Adenocarcinoma.焦亡相关长链非编码 RNA 特征谱揭示了评估肺腺癌患者预后的新标志物。
JCO Precis Oncol. 2024 Mar;8:e2300405. doi: 10.1200/PO.23.00405.